Effects of rofecoxib, celecoxib, and parecoxib on anti-IgE-induced histamine release from human skin mast cells and basophils

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 10, 2003, Pages 1075-1076

  Gibbs, B F ^b   Boehncke, W H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

Basophil; Celecoxib; Cyclooxygenase; Mast cell; Parecoxib; Rofecoxib; Urticaria

Indexed keywords

CELECOXIB; PARECOXIB; ROFECOXIB;

ALLERGIC URTICARIA; ALLERGY TEST; ARTICLE; BASOPHIL; DRUG EFFECT; HISTAMINE METABOLISM; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAST CELL; PRICK TEST; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

ANTIBODIES, ANTI-IDIOTYPIC; BASOPHILS; CYCLOOXYGENASE INHIBITORS; HISTAMINE RELEASE; HUMANS; ISOXAZOLES; LACTONES; MAST CELLS; PYRAZOLES; SKIN; SULFONAMIDES; SULFONES;

EID: 0141922050     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00262.x     Document Type: Article

References (3)

1. BOEHNCKE W-H, LUDWIG RL, ZOLLNER TM, OCHSENDORF FR, KAUFMANN R, GIBBS BF. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. Br J Dermatol 2003;148:1-2.
2. FARNAM J, GRANT JA, LETT-BROWN MA, HUNT C, THUESON DO, GILLAS PC. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. J Immunol 1985;134:541-547.
3. FADEL R, RAMBOER I, CHATTERJEE N, RIHOUX J-P, DERDE M-P. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects. Allergy 2000;55:382-385.